Article
Congress has been warned that many doctors are "on the take" from big pharmaceutical companies, which pay them in one way or another to prescribe their drugs to patients, and are "at risk of corruption" while endangering the lives of patients.
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.